Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Ohba

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
IJU Case Reports|May 11, 2026
Case Report of an Infectious Aortic Aneurysm Following Intravesical Bacillus Calmette-Guérin Therapy After Transurethral Resection of a Bladder TumorDaisuke Muto, Tsuyoshi Matsuda, Shintaro Mori, et al.
International Cancer Conference Journal|January 27, 2026
Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancerYuichiro Nakamura, Hajime Fukushima, Hiroki Kurata, et al.
International Cancer Conference Journal|January 8, 2024
Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case reportAyaka Tsuchiyama, Kojiro Ohba, Hiromi Nakanishi, et al.
Anticancer Research|September 3, 2021
Pathological Roles of Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate CancerYasuyoshi Miyata, Masahito Masato, Yuta Mukae, et al.
In Vivo (Athens, Greece)|October 31, 2019
Four-weekly Low-dose Gemcitabine and Paclitaxel in Patients With Platinum-resistant Urothelial Cancer and Performance Status 2/3Kyohei Araki, Yasuyoshi Miyata, Yuichiro Nakamura, et al.
International Cancer Conference Journal|July 8, 2025
A case of primary malignant melanoma of the ureterMasaharu Oki, Kojiro Ohba, Hiroyuki Honda, et al.
Anticancer Research|September 29, 2020
Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate CancerTsutomu Yuno, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Journal of Clinical Medicine|June 26, 2025
Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal WomenHiroyuki Honda, Tomohiro Matsuo, Hidenori Ito, et al.
International Journal of Molecular Sciences|August 7, 2019
Periodontal Disease in Patients Receiving DialysisYasuyoshi Miyata, Yoko Obata, Yasushi Mochizuki, et al.
Molecular and Clinical Oncology|August 9, 2020
Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trialYasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
IJU Case Reports|May 11, 2026
Case Report of an Infectious Aortic Aneurysm Following Intravesical Bacillus Calmette-Guérin Therapy After Transurethral Resection of a Bladder TumorDaisuke Muto, Tsuyoshi Matsuda, Shintaro Mori, et al.
International Cancer Conference Journal|January 27, 2026
Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancerYuichiro Nakamura, Hajime Fukushima, Hiroki Kurata, et al.
International Cancer Conference Journal|January 8, 2024
Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case reportAyaka Tsuchiyama, Kojiro Ohba, Hiromi Nakanishi, et al.
Anticancer Research|September 3, 2021
Pathological Roles of Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate CancerYasuyoshi Miyata, Masahito Masato, Yuta Mukae, et al.
In Vivo (Athens, Greece)|October 31, 2019
Four-weekly Low-dose Gemcitabine and Paclitaxel in Patients With Platinum-resistant Urothelial Cancer and Performance Status 2/3Kyohei Araki, Yasuyoshi Miyata, Yuichiro Nakamura, et al.
International Cancer Conference Journal|July 8, 2025
A case of primary malignant melanoma of the ureterMasaharu Oki, Kojiro Ohba, Hiroyuki Honda, et al.
Anticancer Research|September 29, 2020
Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate CancerTsutomu Yuno, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Journal of Clinical Medicine|June 26, 2025
Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal WomenHiroyuki Honda, Tomohiro Matsuo, Hidenori Ito, et al.
International Journal of Molecular Sciences|August 7, 2019
Periodontal Disease in Patients Receiving DialysisYasuyoshi Miyata, Yoko Obata, Yasushi Mochizuki, et al.
Molecular and Clinical Oncology|August 9, 2020
Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trialYasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Pageof 14